• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

P2X1受体多重配体结合机制的结构基础

Structural basis of the multiple ligand binding mechanisms of the P2X1 receptor.

作者信息

Qiang Yu-Ting, Wu Peng-Peng, Liu Xin, Peng Li, Zhao Li-Ke, Chen Ya-Ting, Gao Zhao-Bing, Zhao Qiang, Chen Kun

机构信息

School of Pharmacy, Guizhou Medical University, Guizhou, 550025, China.

Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan, 528400, China.

出版信息

Acta Pharmacol Sin. 2025 Apr 2. doi: 10.1038/s41401-025-01512-y.

DOI:10.1038/s41401-025-01512-y
PMID:40175702
Abstract

As important modulators of human purinergic signaling, P2X1 receptors form homotrimers to transport calcium, regulating multiple physiological processes, and are long regarded as promising therapeutic targets for male contraception and inflammation. However, the development of drugs that target the P2X1 receptor, such as the antagonist NF449, is greatly hindered by the unclear molecular mechanism of ligand binding modes and receptor activation. Here, we report the structures of the P2X1 receptor in complex with the endogenous agonist ATP or the competitive antagonist NF449. The P2X1 receptor displays distinct conformational features when bound to different types of compounds. Despite coupling to the agonist ATP, the receptor adopts a desensitized conformation that arrests the ions in the transmembrane (TM) domain, aligning with the nature of the high desensitization rates of the P2X1 receptor within the P2X family. Interestingly, the antagonist NF449 not only occupies the orthosteric pocket of ATP but also interacts with the dorsal fin, left flipper, and head domains, suggesting a unique binding mode to perform both orthosteric and allosteric mechanisms of NF449 inhibition. Intriguingly, a novel lipid binding site adjacent to the TM helices and lower body of P2X1, which is critical for receptor activation, is identified. Further functional assay results and structural alignments reveal the high conservation of this lipid binding site in P2X receptors, indicating important modulatory roles upon lipid binding. Taken together, these findings greatly increase our understanding of the ligand binding modes and multiple modulatory mechanisms of the P2X1 receptor and shed light on the further development of P2X1-selective antagonists.Keywords: Structural biology; Ligand binding mode; Ion channel; Purinergic P2X1 receptor.

摘要

作为人类嘌呤能信号的重要调节因子,P2X1受体形成同源三聚体来转运钙,调节多种生理过程,长期以来一直被视为男性避孕和炎症治疗的有前景靶点。然而,靶向P2X1受体的药物(如拮抗剂NF449)的开发因配体结合模式和受体激活的分子机制不明确而受到极大阻碍。在此,我们报道了P2X1受体与内源性激动剂ATP或竞争性拮抗剂NF449复合物的结构。当与不同类型的化合物结合时,P2X1受体呈现出不同的构象特征。尽管与激动剂ATP偶联,但受体采用脱敏构象,使离子在跨膜(TM)结构域中停滞,这与P2X1受体在P2X家族中高脱敏率的性质一致。有趣的是,拮抗剂NF449不仅占据ATP的正构口袋,还与背鳍、左鳍和头部结构域相互作用,提示其独特的结合模式可同时执行NF449抑制的正构和变构机制。有趣的是,我们鉴定出一个与P2X1的TM螺旋和下体相邻的新型脂质结合位点,该位点对受体激活至关重要。进一步的功能测定结果和结构比对揭示了该脂质结合位点在P2X受体中的高度保守性,表明脂质结合具有重要的调节作用。综上所述,这些发现极大地增进了我们对P2X1受体配体结合模式和多种调节机制的理解,并为P2X1选择性拮抗剂的进一步开发提供了线索。关键词:结构生物学;配体结合模式;离子通道;嘌呤能P2X1受体

相似文献

1
Structural basis of the multiple ligand binding mechanisms of the P2X1 receptor.P2X1受体多重配体结合机制的结构基础
Acta Pharmacol Sin. 2025 Apr 2. doi: 10.1038/s41401-025-01512-y.
2
Evidence of an excitatory purinergic innervation in mouse corpus cavernosum smooth muscle.在小鼠海绵体平滑肌中存在兴奋性嘌呤能神经支配的证据。
J Sex Med. 2024 Oct 31;21(11):977-985. doi: 10.1093/jsxmed/qdae107.
3
Cryo-EM structures of the human P2X1 receptor reveal subtype-specific architecture and antagonism by supramolecular ligand-binding.人类 P2X1 受体的冷冻电镜结构揭示了亚型特异性结构和超分子配体结合的拮抗作用。
Nat Commun. 2024 Oct 1;15(1):8490. doi: 10.1038/s41467-024-52636-4.
4
Use of chimeras, point mutants, and molecular modeling to map the antagonist-binding site of 4,4',4″,4‴-(carbonylbis-(imino-5,1,3-benzenetriylbis(carbonylimino)))tetrakisbenzene-1,3-disulfonic acid (NF449) at P2X1 receptors for ATP.利用嵌合体、点突变体和分子建模来绘制4,4',4″,4‴-(羰基双-(亚氨基-5,1,3-苯三基双(羰基亚氨基)))四苯-1,3-二磺酸(NF449)在ATP的P2X1受体上的拮抗剂结合位点。
J Biol Chem. 2015 Jan 16;290(3):1559-69. doi: 10.1074/jbc.M114.592246. Epub 2014 Nov 25.
5
Structural insights into the human P2X1 receptor and ligand interactions.解析人类 P2X1 受体和配体相互作用的结构见解。
Nat Commun. 2024 Sep 28;15(1):8418. doi: 10.1038/s41467-024-52776-7.
6
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
7
Molecular basis of selective antagonism of the P2X1 receptor for ATP by NF449 and suramin: contribution of basic amino acids in the cysteine-rich loop.NF449 和苏拉明对 ATP 作用的 P2X1 受体选择性拮抗的分子基础:富含半胱氨酸环中碱性氨基酸的作用。
Br J Pharmacol. 2012 Jan;165(2):390-400. doi: 10.1111/j.1476-5381.2011.01534.x.
8
A fluorescent approach for identifying P2X1 ligands.一种用于鉴定P2X1配体的荧光方法。
Neuropharmacology. 2015 Nov;98:13-21. doi: 10.1016/j.neuropharm.2015.05.016. Epub 2015 May 28.
9
Short-Term Memory Impairment短期记忆障碍
10
P2X receptor chimeras highlight roles of the amino terminus to partial agonist efficacy, the carboxyl terminus to recovery from desensitization, and independent regulation of channel transitions.P2X 受体嵌合体突出了氨基末端在部分激动剂效力、羧基末端在脱敏恢复以及通道转变的独立调节中的作用。
J Biol Chem. 2013 Jul 19;288(29):21412-21421. doi: 10.1074/jbc.M113.464651. Epub 2013 Jun 5.

本文引用的文献

1
Structural insights into the orthosteric inhibition of P2X receptors by non-ATP analog antagonists.非 ATP 类似物拮抗剂对 P2X 受体的变构抑制作用的结构见解。
Elife. 2024 Apr 5;12:RP92829. doi: 10.7554/eLife.92829.
2
Structural insights into the allosteric inhibition of P2X4 receptors.P2X4 受体变构抑制的结构见解。
Nat Commun. 2023 Oct 13;14(1):6437. doi: 10.1038/s41467-023-42164-y.
3
The P2X1 receptor as a therapeutic target.P2X1 受体作为治疗靶点。
Purinergic Signal. 2022 Dec;18(4):421-433. doi: 10.1007/s11302-022-09880-4. Epub 2022 Jul 11.
4
Enlightening activation gating in P2X receptors.揭示 P2X 受体的激活门控机制。
Purinergic Signal. 2022 Jun;18(2):177-191. doi: 10.1007/s11302-022-09850-w. Epub 2022 Feb 21.
5
Update of P2X receptor properties and their pharmacology: IUPHAR Review 30.P2X 受体特性及其药理学更新:国际药理学联合会评论 30.
Br J Pharmacol. 2021 Feb;178(3):489-514. doi: 10.1111/bph.15299. Epub 2020 Dec 21.
6
Discovery and Structure Relationships of Salicylanilide Derivatives as Potent, Non-acidic P2X1 Receptor Antagonists.发现并构建水杨酰苯胺衍生物作为强效、非酸性 P2X1 受体拮抗剂的结构关系。
J Med Chem. 2020 Jun 11;63(11):6164-6178. doi: 10.1021/acs.jmedchem.0c00435. Epub 2020 May 27.
7
Full-Length P2X Structures Reveal How Palmitoylation Prevents Channel Desensitization.全长 P2X 结构揭示了棕榈酰化如何防止通道脱敏。
Cell. 2019 Oct 17;179(3):659-670.e13. doi: 10.1016/j.cell.2019.09.017. Epub 2019 Oct 3.
8
Identification of aurintricarboxylic acid as a potent allosteric antagonist of P2X1 and P2X3 receptors.鉴定金顶侧耳酸为 P2X1 和 P2X3 受体的有效别构拮抗剂。
Neuropharmacology. 2019 Nov 1;158:107749. doi: 10.1016/j.neuropharm.2019.107749. Epub 2019 Aug 25.
9
P2X1 ion channel deficiency causes massive bleeding in inflamed intestine and increases thrombosis.P2X1离子通道缺陷导致炎症性肠病大量出血并增加血栓形成。
J Thromb Haemost. 2020 Jan;18(1):44-56. doi: 10.1111/jth.14620. Epub 2019 Sep 10.
10
Druggable negative allosteric site of P2X3 receptors.P2X3 受体的可成药性负变构位点。
Proc Natl Acad Sci U S A. 2018 May 8;115(19):4939-4944. doi: 10.1073/pnas.1800907115. Epub 2018 Apr 19.